Anna Maria Caridis

Anna Maria Caridis has a diverse work experience in the scientific research field. Anna Maria currently works as a Research and Development Scientist at QuantuMDx Group Limited since November 2020. Prior to this, they held the position of Postdoctoral Researcher at the University of Birmingham from September 2017 to December 2019, where their research focused on bladder cancer and epigenetic modulators. Anna Maria also worked as a PhD Student at Glasgow Caledonian University from October 2012 to June 2017, studying mitochondrial cholesterol trafficking and insulin secretion in type 2 diabetes. In addition, they gained research experience through summer placements at the University of Glasgow in 2010 and at the Biomedical Research Foundation of the Academy of Athens in 2006.

Anna Maria Caridis has an extensive education history. Anna Maria obtained their Doctor of Philosophy - PhD in Biochemistry with a focus on Type 2 Diabetes from Glasgow Caledonian University, which they attended from 2012 to 2017. Prior to this, they completed their MRes in Biomedical Sciences at the University of Glasgow from 2010 to 2011. Before pursuing their master's degree, Anna Maria earned a BSc Hons in Medical Biochemistry from the University of Glasgow, though the specific start year is not provided. Going further back, they attended The Moraitis School from 2002 to 2004, where they earned an IB diploma. Their earliest education was at Arsakeia - Tositseia Schools, where they completed their schooling from 1996 to 2002.